Nifty Bank 53708.1 (2.10)
Nifty IT 29671.3 (0.08)
Nifty Next 50 63620.6 (2.02)
Nifty Smallcap 100 15896.55 (2.59)
Nifty Pharma 22679.75 (1.98)
SENSEX 75273.45 (1.63)
Nifty Midcap 100 55331.05 (2.30)
Nifty 50 23306.45 (1.72)
NIKKEI 225 54111.32 (0.67)
HANG SENG 25335.95 (1.09)
S&P 6651 (-0.03)
(19 Mar 2026, 13:26)
Formulations & CDMO Player
Pursuing acquisitions to expand portfolio and market reach
Sai Parenteral‘s is a diversified pharmaceutical formulations company with expertise in research, development, and manufacturing. The company operates across two segments: (1) Branded Generic Formulations and (2) Contract Development and Manufacturing Organisation (CDMO) products and services for domestic and international markets. Branded Generic Formulations refer to off-patent pharmaceutical products marketed under proprietary brand names. The CDMO segment provides end-to-end services. These include product development and validation batches, which are trial runs to ensure consistent manufacturing quality. In addition, the segment handles dossier compilation, prepares regulatory documentation, manages international regulatory filings for product...
(23-Mar-26 20:05)
(19-Mar-26 15:36)
(19-Mar-26 19:37)
(13-Mar-26 17:10)
IPO Centre - IPO News (25-Mar-26 17:05)
IPO Centre - IPO News (24-Mar-26 17:11)